Strikingly, in 20% the melanoma cells themselves were SLAMF9 positive while only 2.3% of melanocytic naevus cells derived from melanoma patients and none of the naevi from healthy donors showed SLAMF9 expression. Here, SLAMF9 is linked to melanoma.